Nasopharyngeal News and Research

RSS

Researchers show role of Epstein-Barr virus in cancer

Researchers at the University of Toronto have mapped the molecular details that show how a viral protein coded in the Epstein-Barr virus immortalizes cells and causes them to continuously grow, thereby predisposing people to certain types of cancer.

3 Apr 2005

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers.

15 Mar 2005

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

A typically innocuous virus found in 90 percent of people worldwide is the key to a new treatment for a cancer particularly common in North Africa and Southeast Asia.

16 Feb 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Health problems among timber workers exposed to industry chemical PCP are to be investigated

The project, funded by the Ministry of Health, aims to ascertain whether timber workers exposed to the PCPs (pentachlorophenols) are dying earlier, getting cancers more often and suffering more chronic health problems, including fatigue, nausea and neuropsychological dysfunction.

13 Sep 2004

Suctioning babies to prevent a potentially fatal respiratory disease is probably ineffective

The widely practised procedure of suctioning babies to prevent a potentially fatal respiratory disease is probably ineffective, conclude authors of a study in this week’s issue of THE LANCET. Suctioning is used to remove mucus from baby’s airway or breathing passages.

15 Aug 2004

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

9 Aug 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Nasopharyngeal News and Research

Researchers show role of Epstein-Barr virus in cancer

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Health problems among timber workers exposed to industry chemical PCP are to be investigated

Suctioning babies to prevent a potentially fatal respiratory disease is probably ineffective

Aggressive treatment for nasopharyngeal cancer shown to be more effective

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News